SKI Market

Indian Indices

Sensex

84,481.81 -77.84
( -0.09%)

Global Indices

Nasdaq

47,912.86 -222.41
(-0.46%)

Dow Jones

6,743.36 -77.90
(-1.14%)

Hang Seng

49,082.83 -429.45
(-0.87%)

Nikkei 225

9,795.97 111.18
(1.15%)

Forex

USD-INR

90.90 0.23
(0.25%)

EUR-INR

106.88 0.39
(0.37%)

GBP-INR

121.83 0.57
(0.47%)

JPY-INR

0.59 0.00
(0.54%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

461.79599

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

10.88

16522.89

EPS(TTM)

Face Value()

Div & Yield %

84.75

0.65

Back

Pan India Corporation Ltd - Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 14TH OCTOBER 2025

Oct 14,2025

The Board of Directors at its meeting held today i.e. 14th October 2025 have considered and approved the following agenda items: A) The Un-Audited Standalone Financial Results for the Quarter and Half Year Ended 30th September 2025; B) Any other items as mentioned in the agenda.

84,481.81 -77.84 ( -0.09%)

47,912.86 -222.41 (-0.46%)

6,743.36 -77.90 (-1.14%)

49,082.83 -429.45 (-0.87%)

9,795.97 111.18 (1.15%)

90.90 0.23 (0.25%)

106.88 0.39 (0.37%)

121.83 0.57 (0.47%)

0.59 0.00 (0.54%)